GT Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer with a DRAP-listed GMP manufacturing facility at Sundar Industrial Estate.
GT Pharma products in Pakistan
GT Pharma Pvt. Ltd has 47 medicine presentations registered in Pakistan under 27 brands, covering 21 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Hematology & thrombosis. Its brands with the most registered strengths and packs are Artful (Artemether + Lumefantrine, Artemether), GT Zole (Fluconazole), GT-Sturt (Ondansetron) and G Tant (Aprepitant). 47 products have an official DRAP price on MedInfoBase. See all 27 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- GT Pharma (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 713, Sundar Industrial Estate, Lahore, Punjab, Pakistan
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 50%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where GT Pharma Pvt. Ltd is priced against the market
37 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Artful | Artemether | 80 mg/mL | Injection | 6'sx1ml | 080672 | PKR 1,196.82 | PKR 199.47/mL | 🔒 Pharma Pro |
| Artful | Artemether + Lumefantrine | 15 mg/5 mL + 90 mg/5 mL | Dry suspension | 30ml | 080681 | PKR 179.52 | PKR 5.98/mL | 🔒 Pharma Pro |
| Artful | Artemether + Lumefantrine | 30 mg/5 mL + 180 mg/5 mL | Dry suspension | 30ml | 080682 | PKR 299.20 | PKR 9.97/mL | No comparator |
| Artful | Artemether | 40 mg/mL | Injection | 10's | 086376 | PKR 1,196.82 | PKR 119.68/vial/unit | 🔒 Pharma Pro |
| Casita 1 g Injection IVRegistry verified | Ceftriaxone sodium eq, to Ceftriaxone | — | — | — | 119081Official source ↗ | No indexed price | — | — |
| Casita 250mg Injection IVRegistry verified | Ceflriaxone sodium eq. to Ceftriaxone | — | — | — | 119079Official source ↗ | No indexed price | — | — |
| Casita 500mg Injection IMRegistry verified | Ceftriaxone sodium eq, to Ceftriaxone | — | — | — | 119080Official source ↗ | No indexed price | — | — |
| ED-3 1 ml | Cholecalciferol | 5 mg/mL | Injection | 1's | 080881 | PKR 226.58 | PKR 226.58/vial/unit | 🔒 Pharma Pro |
| Estrum | Esomeprazole | 40 mg | Injection | 14's | 096542 | PKR 279.58 | PKR 19.97/vial/unit | 🔒 Pharma Pro |
| Estrum 40mg InjectionRegistry verified | Esomeprazole as sodium | — | — | — | 104924Official source ↗ | No indexed price | — | — |
| G Azithro | Azithromycin | 250 mg | Capsule | 10's | 080679 | PKR 508.65 | PKR 50.87/capsule | 🔒 Pharma Pro |
| G Azithro Dry Powder | Azithromycin | 200 mg/5 mL | Suspension | 15ml | 103423 | PKR 284.75 | PKR 18.98/mL | 🔒 Pharma Pro |
| G Strontium Sachet 2gRegistry verified | Strontium ranelate | — | — | — | 080689Official source ↗ | No indexed price | — | — |
| G Tant | Aprepitant | 80 mg | Capsule | 2's | 080678 | PKR 3,336.92 | PKR 1,668.46/capsule | 🔒 Pharma Pro |
| G Tant | Aprepitant | 40 mg | Capsule | 2's | 080880 | PKR 1,998.03 | PKR 999.02/capsule | 🔒 Pharma Pro |
| G Tant | Aprepitant | 125 mg | Capsule | 2's | 086437 | PKR 5,211.35 | PKR 2,605.68/capsule | 🔒 Pharma Pro |
| GT Cip | Ciprofloxacin | 125 mg/5 mL | Suspension | 60ml | 080672 | PKR 185.88 | PKR 3.10/mL | 🔒 Pharma Pro |
| GT Cip 100ml | Ciprofloxacin | 200 mg/100 mL | IV infusion | 1x100ml | 080676 | PKR 199.47 | PKR 1.99/mL | 🔒 Pharma Pro |
| GT Dol | Haloperidol | 5 mg/mL | Injection | 1ml x 25's | 080674 | PKR 329.13 | PKR 13.17/mL | No comparator |
| GT Gut Low Osmolarity ORSSource observed | — | — | Sachet | 20's | 083185Official source ↗ | No indexed price | — | — |
| GT Line | Linezolid | 200 mg/100 mL | IV infusion | 1'sx100ml | 080879 | PKR 690.17 | PKR 6.90/mL | 🔒 Pharma Pro |
| GT Line | Linezolid | 600 mg/300 mL | IV infusion | 1's | 095849 | PKR 1,164.90 | PKR 1,164.90/vial/unit | 🔒 Pharma Pro |
| GT Line Dry Powder Granules | Linezolid | 100 mg/5 mL | Suspension | 60ml | 083161 | PKR 698.14 | PKR 11.64/mL | 🔒 Pharma Pro |
| GT Mox | Moxifloxacin | 400 mg | IV infusion | 250mlx1's | 080675 | PKR 2,170.80 | PKR 8.68/mL | 🔒 Pharma Pro |
| GT Mycim | Clarithromycin | 125 mg/5 mL | Drops | 25ml | 093182 | PKR 180.56 | PKR 7.22/mL | No comparator |
| GT Mycim granules for susp | Clarithromycin | 250 mg/5 mL | Suspension | 60ml | 080683 | PKR 736.04 | PKR 12.27/mL | 🔒 Pharma Pro |
| GT Mycim granules for susp | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 080685 | PKR 444.82 | PKR 7.41/mL | 🔒 Pharma Pro |
| GT Zole | Fluconazole | 150 mg | Capsule | 4's | 080680 | PKR 1,013.31 | PKR 253.33/capsule | 🔒 Pharma Pro |
| GT Zole | Fluconazole | 150 mg | Capsule | 1's | 080680 | PKR 275.27 | PKR 275.27/capsule | 🔒 Pharma Pro |
| GT Zole | Fluconazole | 50 mg | Capsule | 7's | 092587 | PKR 873.67 | PKR 124.81/capsule | 🔒 Pharma Pro |
| GT Zole | Fluconazole | 200 mg | Capsule | 4's | 096731 | PKR 931.92 | PKR 232.98/capsule | 🔒 Pharma Pro |
| GT Zole Dry Powder | Fluconazole | 50 mg/5 mL | Suspension | 35ml | 080684 | PKR 418.89 | PKR 11.97/mL | 🔒 Pharma Pro |
| GT-CIP Dry Powder | Ciprofloxacin | 250 mg/5 mL | Suspension | 60ml | 108446 | PKR 276.12 | PKR 4.60/mL | 🔒 Pharma Pro |
| GT-CIP Dry Powder | Ciprofloxacin | 500 mg/5 mL | Suspension | 30ml | 108447 | PKR 276.12 | PKR 9.20/mL | 🔒 Pharma Pro |
| GT-Grit | Iron polymaltose complex | 150 mg | Capsule | 30's | 108191 | PKR 569.51 | PKR 18.98/capsule | 🔒 Pharma Pro |
| GT-Sturt | Ondansetron | 4 mg/5 mL | Syrup | 25ml | 108190 | PKR 353.17 | PKR 14.13/mL | 🔒 Pharma Pro |
| GT-Sturt | Ondansetron | 4 mg/5 mL | Syrup | 50ml | 108190 | PKR 862.89 | PKR 17.26/mL | 🔒 Pharma Pro |
| GT-Sturt | Ondansetron | 8 mg/4 mL | Injection | 4mlx1's | 108441 | PKR 892.23 | PKR 223.06/mL | 🔒 Pharma Pro |
| GT-Sturt | Ondansetron | 4 mg/2 mL | Injection | 2mlx1's | 108442 | PKR 664.43 | PKR 332.22/mL | 🔒 Pharma Pro |
| K Lot Pediatric | Phytomenadione | 2 mg/1 mL | Injection | 5's | 083184 | PKR 721.07 | PKR 144.21/vial/unit | No comparator |
| K Lot Pediatric | Phytomenadione | 2 mg/1 mL | Injection | 1's | 083184 | PKR 159.58 | PKR 159.58/vial/unit | No comparator |
| K-LOT | Phytomenadione | 10 mg/mL | Injection | 5's | 106359 | PKR 1,254.45 | PKR 250.89/vial/unit | 🔒 Pharma Pro |
| K-LOT | Phytomenadione | 10 mg/mL | IV injection | 1's | 106359 | PKR 277.63 | PKR 277.63/vial/unit | No comparator |
| Kalpac 1000mg InjectionRegistry verified | Cefepime HCI Monohydrate eq. to Cefepime | — | — | — | 119083Official source ↗ | No indexed price | — | — |
| Kalpac 500mg InjectionRegistry verified | Cefepime HCI Monohydrate eq. to Cefepime | — | — | — | 119082Official source ↗ | No indexed price | — | — |
| Mizuna | Omeprazole | 40 mg | Capsule | 14's | 096541 | PKR 485.38 | PKR 34.67/capsule | 🔒 Pharma Pro |
| Mizuna | Omeprazole | 20 mg | Capsule | 1's | 096542 | PKR 431.45 | PKR 431.45/capsule | 🔒 Pharma Pro |
| Mizuna | Omeprazole | 40 mg | Injection | 1's | 104923 | PKR 517.73 | PKR 517.73/vial/unit | 🔒 Pharma Pro |
| Ofbel | Ofloxacin | 200 mg/100 mL | IV infusion | 1's | 095848 | PKR 194.15 | PKR 194.15/vial/unit | 🔒 Pharma Pro |
| Panoram 1gm InjectionRegistry verified | Meropenem | — | — | — | 131755Official source ↗ | No indexed price | — | — |
All 27 GT Pharma brands in Pakistan
- Artful Artemether + Lumefantrine, Artemether · 15 mg/5 mL + 90 mg/5 mL suspension, 30 mg/5 mL + 180 mg/5 mL suspension, 40 mg/mL injection
- ED-3 1 ml Cholecalciferol · 5 mg/mL injection
- Estrum Esomeprazole · 40 mg injection
- G Azithro Azithromycin · 250 mg capsule
- G Azithro Dry Powder Azithromycin · 200 mg/5 mL suspension
- G Tant Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
- GT Cip Ciprofloxacin · 125 mg/5 mL suspension
- GT Cip 100ml Ciprofloxacin · 200 mg/100 mL infusion
- GT Dol Haloperidol · 5 mg/mL injection
- GT Line Linezolid · 200 mg/100 mL infusion, 600 mg/300 mL infusion
- GT Line Dry Powder Granules Linezolid · 100 mg/5 mL suspension
- GT Mox Moxifloxacin · 400 mg infusion
- GT Mycim Clarithromycin · 125 mg/5 mL drops
- GT Mycim granules for susp Clarithromycin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
- GT Zole Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg capsule
- GT Zole Dry Powder Fluconazole · 50 mg/5 mL suspension
- GT-CIP Dry Powder Ciprofloxacin · 250 mg/5 mL suspension, 500 mg/5 mL suspension
- GT-Grit Iron polymaltose complex · 150 mg capsule
- GT-Sturt Ondansetron · 4 mg/2 mL injection, 4 mg/5 mL syrup, 8 mg/4 mL injection
- K Lot Pediatric Phytomenadione · 2 mg/1 mL injection
- K-LOT Phytomenadione · 10 mg/mL injection
- Mizuna Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
- Ofbel Ofloxacin · 200 mg/100 mL infusion
- Persil Diclofenac · 75 mg/3 mL injection
- Pyrenol Paracetamol · 1000 mg/100 mL injection
- Surfer Iron sucrose · 100 mg/5 mL injection
- Trebac Levofloxacin · 500 mg/100 mL infusion
GT Pharma: common questions
How many products does GT Pharma have in Pakistan?
GT Pharma Pvt. Ltd has 47 registered medicine presentations in Pakistan, sold under 27 brands and covering 21 generic medicines.
What are the main brands of GT Pharma?
By number of registered strengths and packs, its largest brands are Artful (Artemether + Lumefantrine, Artemether), GT Zole (Fluconazole), GT-Sturt (Ondansetron), G Tant (Aprepitant) and Mizuna (Omeprazole). This is not a sales ranking.
Which therapy areas does GT Pharma cover?
The most products are in Anti-infectives (24), Gastrointestinal & hepatology (11), Hematology & thrombosis (4), Pain & musculoskeletal (4) and Vitamins, minerals & nutrition (3).
Where can I see GT Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.